Genomic Characterization of PDX Models for Breast Cancer Brain Metastases
Demographics (2)
- age_at_surgery - Age at surgical resection (phv00259009.v1.p1)
- sex - Gender of participant (phv00259008.v1.p1)
Disease Events (6)
- Brain_met_ER - Brain metastases ER status (phv00259016.v1.p1)
- Brain_met_HER2 - Brain metastases HER2 status (phv00259015.v1.p1)
- Brain_met_PR - Brain metastases PR status (phv00259017.v1.p1)
- chemotherapy - Patient chemotherapy information before surgery (phv00259019.v1.p1)
- Radiation - Patient radiation information before surgery (phv00259021.v1.p1)
- target_therapy - Patient target therapy information before surgery (phv00259018.v1.p1)
Medications (1)
- Hormone therapy - Patient hormone therapy information before surgery (phv00259020.v1.p1)
Other (11)
- ANALYTE_TYPE - Sample content analyzed (phv00259011.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00259003.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00259014.v1.p1)
- IS_PDX - Whether the sample is from patient-derived xenograft (PDX) (phv00259013.v1.p1)
- IS_TUMOR - Whether the sample is tumor (phv00259012.v1.p1)
- SAMPID - De-identified Sample ID (phv00259010.v1.p1)
- SAMPID - Sample ID (phv00259005.v1.p1)
- SAMPLE_USE - Method in which sample was analyzed. Seq_DNA_SNP: SNP genotypes derived from sequence data; Seq_DNA_WholeExome: Whole exome sequencing (phv00259006.v1.p1)
- SUBJID - Subject ID (phv00259004.v1.p1)
- SUBJID - De-identified Subject ID (phv00259007.v1.p1)
- SUBJID - Subject ID (phv00259002.v1.p1)